Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Read More Pharma Industry News Be Biopharma reports positive preclinical data for BE-102 in hypophosphatasia Be Biopharma shares preclinical results for BE-102, a B cell medicine in development for treating hypophosphatasia. Read about its novel approach. byPallavi MadhirajuMay 18, 2025